Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa
-
Published:2024-11
Issue:
Volume:267
Page:122-134
-
ISSN:0002-9394
-
Container-title:American Journal of Ophthalmology
-
language:en
-
Short-container-title:American Journal of Ophthalmology
Author:
MICHAELIDES MICHEL, BESIRLI CAGRI G.ORCID, YANG YESA, DE GUIMARAES THALES A.C.ORCID, WONG SUI CHIENORCID, HUCKFELDT RACHEL M., COMANDER JASON I., SAHEL JOSÉ-ALAINORCID, SHAH SYED MAHMOOD, TEE JAMES J.L., KUMARAN NERUBANORCID, GEORGIADIS ANASTASIOS, MINNICK PANSYORCID, ZELDIN ROBERT, NAYLOR STUART, XU JIALIN, CLARK MICHAELORCID, ANGLADE EDDY, WONG PEGGY, FLECK PENNY R., FUNG ALBERT, PELUSO COLLEENORCID, KALITZEOS ANGELOSORCID, GEORGIOU MICHALISORCID, RIPAMONTI CATERINA, SMITH ALEXANDER J.ORCID, ALI ROBIN R., FORBES ALEXANDRIA, BAINBRIDGE JAMES
|
|